首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human APP Recombinant Antibody(Donanemab)

Anti-Human APP Recombinant Antibody(Donanemab)

产品编号

YR1541

别名

科研级 Donanemab (多奈单抗 ), Anti-APP Recombinant Antibody, Research Grade Donanemab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Donanemab (多奈单抗 ), Anti-APP Recombinant Antibody, Research Grade Donanemab
Catalog NumberYR1541
Molecular NameDonanemab
CAS Number1931944-80-7
TargetAPP[Homo sapiens]
Antibody IsotypeIgG1 Kappa
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundDonanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials.
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价